 | Short Interest in Aptevo Therapeutics Inc (NASDAQ:APVO) Declines By 10.7%
www.americanbankingnews.com - February 14 at 5:23 PM |
 | Aptevo Therapeutics Inc. Common Stock (APVO) Insider Activity
www.nasdaq.com - February 14 at 12:41 AM |
| Contrasting Sernova (OTCMKTS:SEOVF) & Aptevo Therapeutics (OTCMKTS:APVO)
www.americanbankingnews.com - February 13 at 6:47 PM |
| Aptevo Therapeutics Inc. Common Stock (APVO) Revenue EPS
www.nasdaq.com - February 12 at 5:20 PM |
| Aptevo Therapeutics Inc. Common Stock (APVO) Dividend History
www.nasdaq.com - February 12 at 5:20 PM |
| Aptevo Therapeutics Inc (NASDAQ:APVO) Given Consensus Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - February 2 at 12:31 PM |
 | Aptevo Therapeutics Doses First Patient in IXINITY Clinical Trial for Potential Pediatric Label Expansion
finance.yahoo.com - January 30 at 11:49 AM |
| Aptevo Therapeutics Inc. (APVO): Are Hedge Funds Right About This Stock?
finance.yahoo.com - December 19 at 6:51 PM |
| Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous Leukemia
finance.yahoo.com - December 6 at 1:23 PM |
 | Alligator Bioscience AB Appoints Chief Operating Officer
www.prnewswire.com - November 29 at 3:28 AM |
| What Makes Aptevo Therapeutics Inc. (APVO) a New Buy Stock
finance.yahoo.com - November 12 at 12:31 PM |
 | Aptevo Therapeutics EPS beats by $0.01, beats on revenue
seekingalpha.com - November 7 at 12:55 PM |
| Aptevo Therapeutics Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 7 at 12:55 PM |
| Aptevo Therapeutics: Profitability Might Be 12 Months Away
seekingalpha.com - October 8 at 2:04 PM |
 | BRIEF-Aptevo Therapeutics Reports Decision To Discontinue Development Of APVO210
www.msn.com - October 3 at 9:40 PM |
| Aptevo Therapeutics Provides Corporate and Pipeline Update
finance.yahoo.com - October 3 at 4:34 PM |
| Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors
finance.yahoo.com - September 19 at 1:45 PM |
| Aptevo Therapeutics: IXINITY Revenue Still The Focus
seekingalpha.com - August 22 at 6:20 PM |
| Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 9 at 9:18 AM |
| Aptevo Therapeutics Receives $4.3 Million Milestone Payment From Saol International Limited
finance.yahoo.com - August 7 at 10:46 AM |
| Buy Aptevo Therapeutics Before Their Q2 Results
seekingalpha.com - July 30 at 9:34 AM |
| BRIEF-Aptevo Therapeutics Reports Continued Progress In Apvo210 And Apvo436 Clinical Trials
www.msn.com - July 25 at 9:50 PM |
| Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials
finance.yahoo.com - July 25 at 4:48 PM |
| Friday 7/12 Insider Buying Report: PBHC, APVO
www.nasdaq.com - July 13 at 11:18 AM |
 | Aptevo Announces Pricing of $22 Million Offering of Common Stock and Warrants
www.globenewswire.com - July 4 at 5:20 PM |
| Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User Experience and Improved Convenience for Hemophilia B Patients
finance.yahoo.com - June 25 at 9:55 AM |
| Aptevo Therapeutics EPS in-line, beats on revenue
seekingalpha.com - May 9 at 6:05 PM |
| Aptevo Therapeutics Reports First Quarter 2019 Financial Results
www.globenewswire.com - May 9 at 9:48 AM |
| Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
finance.yahoo.com - April 15 at 10:42 AM |
| What Kind Of Investor Owns Most Of Aptevo Therapeutics Inc. (NASDAQ:APVO)?
finance.yahoo.com - April 11 at 6:02 PM |
| Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Association for Cancer Research 2019 Annual Meeting
finance.yahoo.com - April 2 at 12:27 PM |
| Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Association for Cancer Research 2019 Annual Meeting
finance.yahoo.com - March 25 at 9:35 AM |
| Aptevo Therapeutics begins phase 1 trial of APVO210; shares up 11% premarket
seekingalpha.com - March 20 at 6:12 PM |
 | Form SC 13G Aptevo Therapeutics Inc. Filed by: Stonepine Capital Management, LLC - StreetInsider.com
www.streetinsider.com - March 20 at 9:31 AM |
| Form 8-K Aptevo Therapeutics Inc. For: Mar 18 - StreetInsider.com
www.streetinsider.com - March 20 at 9:31 AM |
| Aptevo Therapeutics (APVO) Commences Phase 1 Clinical Trial of APVO210 for the Treatment of Autoimmune and Inflammatory Diseases - StreetInsider.com
www.streetinsider.com - March 20 at 9:31 AM |
| Aptevo Therapeutics Begins Phase 1 Clinical Trial of APVO210 a Novel Bispecific Antibody for the Treatment of Autoimmune and Inflammatory Diseases - GlobeNewswire
www.globenewswire.com - March 20 at 9:31 AM |
| Aptevo Therapeutics Begins Phase 1 Clinical Trial of APVO210 a Novel Bispecific Antibody for the Treatment of Autoimmune and Inflammatory Diseases
finance.yahoo.com - March 20 at 9:31 AM |
| Aptevo Therapeutics Reports 2018 Financial Results and Provides Business Update - GlobeNewswire
globenewswire.com - March 18 at 6:13 PM |
| Aptevo Therapeutics Reports 2018 Financial Results and Provides Business Update
www.globenewswire.com - March 18 at 9:32 AM |
| Aptevo Therapeutics Reports 2018 Financial Results and Provides Business Update
finance.yahoo.com - March 18 at 9:32 AM |
| Aptevo Therapeutics Inc. (APVO) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - March 14 at 5:59 PM |
| Aptevo Therapeutics Inc. (APVO)
finance.yahoo.com - March 11 at 10:39 AM |
| Aptevo down 45% on pricing of equity offering
seekingalpha.com - March 7 at 10:35 AM |
| Aptevo Announces Proposed Public Offering of Common Stock and Warrants
finance.yahoo.com - March 6 at 6:02 PM |
| Aptevo Therapeutics +5.3% after projecting cut in cash burn
seekingalpha.com - January 7 at 5:11 PM |
| Aptevo Therapeutics Highlights Key 2019 Priorities
finance.yahoo.com - January 7 at 9:33 AM |
| Aptevo Therapeutics Collects $3.3 Million In Escrow Funds From Saol Therapeutics
finance.yahoo.com - January 3 at 9:51 AM |
| Aptevo Therapeutics Announces Up To $35 Million Common Stock Purchase Agreement With Lincoln Park Capital
finance.yahoo.com - December 21 at 9:33 AM |
| Need To Know: Aptevo Therapeutics Inc. (NASDAQ:APVO) Insiders Have Been Buying Shares
finance.yahoo.com - December 20 at 4:36 PM |
